Burning-Mouth Trial Separated Symptom Improvement From Complete Recovery With Clonazepam

Improved pain scores did not mean that most patients experienced complete resolution.

What the supplied source reports

Sixty patients were randomized to four weeks of clonazepam treatment or a tongue protector. Pain ratings improved more in the clonazepam group, but complete recovery was reported for only three clonazepam recipients and one tongue-protector recipient. The investigators also assessed psychological and quality-of-life measures.

Limits of the evidence

The trial lacked complete blinding, and subjective pain is vulnerable to expectations. The short treatment period does not establish long-term benefit, dependence risk or sustained relief after discontinuation. Psychological correlations do not prove that the pain syndrome is caused by mood symptoms.

Implications for forensic interpretation

For expert discussion, report the actual outcome: a change in pain rating, a responder definition or complete recovery. These are not interchangeable. The source supports a limited comparative observation in the studied population rather than a broad claim that clonazepam cures burning-mouth syndrome or that response determines the underlying cause.

Source and related reading

Source reviewed: Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome (PMC9330819). Forensic applications above are interpretive analysis of the supplied publication.